- Quadrant Research Foundation has reported that a process called the Maillard reaction, a spontaneous reaction between sugars and proteins which leads to the formation of glycated proteins in the body, can result in the formation of amyloid plaques which are implicated in Alzheimer's disease. The firm says that this discovery should allow the development of inhibitors to the Maillard reaction, which could lead to a treatment for the disease and other neurodegenerative disorders.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze